Xcout Intel
Centessa Pharmaceuticals plc
Centessa Pharmaceuticals LLC is a biotechnology research company headquartered in Boston, Massachusetts, United States. The company comprises leaders, innovators, and scientists dedicated to pursuing and developing transformational medicines for patients.
Subscribe to see Centessa Pharmaceuticals plc’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
Centessa Pharmaceuticals plc at a glance
Centessa Pharmaceuticals plc is a biotechnology company headquartered in Altrincham, United Kingdom, founded in 2020. It is publicly listed (CNTA) with a market capitalisation of $6.3B. Xcout tracks 19 named people at Centessa Pharmaceuticals plc, including Mario Alberto Accardi (Chief Executive Officer & Director). Xcout recorded 63 job postings from Centessa Pharmaceuticals plc in the last 90 days, naming tools such as SAP.
Centessa Pharmaceuticals plc leadership
- Mario Alberto AccardiChief Executive Officer & Director
- John J. CrowleyChief Financial Officer
- Stephen J. KanesHead of R&D and Chief Medical Officer
- Iqbal J. HussainChief Legal Officer, Chief Compliance Officer & Company Secretary
- Gregory WeinhoffChief Business Officer
- Karen AndersonChief People Officer
13 more named people on record for Centessa Pharmaceuticals plc, with roles, board committees and tenure — see the full roster →
Hiring at Centessa Pharmaceuticals plc
Xcout recorded 63 job postings from Centessa Pharmaceuticals plc in the last 90 days, from a hiring record Xcout has kept since June 2026.
Tools named in Centessa Pharmaceuticals plc's job postings
The weekly hiring trend, the roles and locations behind it — see Centessa Pharmaceuticals plc's hiring signals →
Recent Centessa Pharmaceuticals plc news
- AcquisitionLilly completes acquisition of Centessa Pharmaceuticals to advance treatments for sleep-wake disorders - PR Newswire
- AcquisitionLilly to acquire Centessa in deal worth up to $7.8bn - PMLiVE
5 corporate events on record, with sources — see the full timeline →
Hiring vs the trend
Based on 47 job postings in the last 8 weeks (17 Aug – 11 Oct 2026), compared with 181 scale-up healthcare companies.
This describes a hiring pattern — how often Centessa Pharmaceuticals plc’s job postings ask for AI skills, and how that changed against the previous 8 weeks, ranked among its peers. It says nothing about the company’s products or performance.
Signed-in members see the AI-skill share and its change with peer percentiles, role mix, posting momentum and advertised US pay against the market.
Tech stack
Centessa Pharmaceuticals plc competitors
A few of Centessa Pharmaceuticals plc's closest competitors — see the full list of competitors and alternatives →
FogPharma, also known as Parabilis Medicines, is a clinical-stage biopharmaceutical and biotechnology research company headquartered in Cambridge, Massachusetts. The company is dedicated to creating novel therapeutics.
Delphia Therapeutics is a biotechnology research company headquartered in Cambridge, Massachusetts, with a team of 11 to 50 employees focused on therapeutic innovations.
Imviva Biotech is a clinical-stage biotechnology company developing innovative therapies, including the TENACITY-01 CAR-T cell therapy clinical trial. The firm is associated with operations in Boston, Massachusetts, and works alongside other major biotechnology entities.
Tasca Therapeutics is a biotechnology research company based in Cambridge, Massachusetts, leveraging a unique platform to exploit lipid-binding pockets on proteins.
Proterris, Inc. is a biotechnology company headquartered in Massachusetts, United States, specializing in therapeutic research and development.
Cerevance is a pharmaceutical and biotechnology research company based in Boston, Massachusetts, that uses its proprietary NETSseq platform to develop cell-type specific treatments. The company focuses on neurodegenerative, psychiatric, and central nervous system-controlled metabolic disorders.
Get Centessa Pharmaceuticals plc's news by email
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Share this card
Post the link and the card appears automatically — each network fetches the image itself.
More on Centessa Pharmaceuticals plc in Xcout Intel
- 19 named people with titles, LinkedIn and board committees
- Weekly hiring history and the mix of roles behind it
- 5 corporate events with sources — deals, leadership changes, layoffs
- The full competitor set, tracking, exports and API access